Clearside Biomedical
CLSD
CLSD
53 hedge funds and large institutions have $10.2M invested in Clearside Biomedical in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $13.6M → $10.2M (-$3.39M)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
53
Holding in Top 10
–
Calls
$229K
Puts
$59K
Top Buyers
1 | +$190K | |
2 | +$117K | |
3 | +$73K | |
4 |
E
Ergoteles
New York
|
+$61.4K |
5 |
B
Bailard
Foster City,
California
|
+$53.5K |
Top Sellers
1 | -$438K | |
2 | -$273K | |
3 | -$173K | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$130K |
5 |
Millennium Management
New York
|
-$118K |